PMID: 15232242Jul 3, 2004Paper

Utility of anaerobic blood cultures in a pediatric emergency department

Pediatric Emergency Care
Stephen B Freedman, Genie E Roosevelt

Abstract

To determine the frequency with which clinically significant bacterial pathogens are isolated only from the anaerobic blood culture medium in children evaluated for bacteremia and to describe the clinical features associated with these positive cultures. Retrospective review of all blood cultures received from the emergency department in the microbiology laboratory. Clinically significant pathogens were defined as microorganisms that rarely are considered to be contaminants or microorganisms that are recovered from multiple blood cultures or sites from the same individual. Charts of all patients with positive anaerobic cultures for clinically significant pathogens in the presence of negative aerobic cultures were reviewed. The setting was an urban tertiary care pediatric emergency department. 2675 paired blood cultures were performed between January 1, 1998 and December 31, 2000. Growth of a bacterial organism occurred in 595 of the paired samples. Two hundred seventy-eight were clinically significant pathogens. One hundred sixty-two (58.3%) were present in both the aerobic and anaerobic mediums, 85 (30.6%) were only in the aerobic medium, and 31 (11.2%) were only in the anaerobic medium. Most patients with growth only in the a...Continue Reading

References

Jul 1, 1991·Reviews of Infectious Diseases·C W DorsherD M Ilstrup
Jun 1, 1988·Pediatric Clinics of North America·K M Butler, C J Baker
Aug 1, 1995·The Journal of Pediatrics·A K ZaidiL B Reller
Aug 15, 1993·Annals of Internal Medicine·L A Mermel, D G Maki
Nov 5, 1997·The Pediatric Infectious Disease Journal·L C ThulerM H Lebel
Mar 11, 1998·Pediatrics·K B Sadow, J M Chamberlain
Jun 2, 1998·Pediatrics·R E Davis, I Osorio
Apr 13, 2000·Pediatric Clinics of North America·L G Rubin
May 12, 2000·Archives of Pediatrics & Adolescent Medicine·G S Segal, J M Chamberlain
Dec 12, 2001·Primary Care·A L Campbell, K A Bryant
Mar 29, 1958·Lancet·E J STOKES

❮ Previous
Next ❯

Citations

Mar 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W Hecht
Jan 22, 2005·Current Opinion in Pediatrics·Paul McCarthy
Mar 27, 2007·Annals of Emergency Medicine·Linda F McCaigMatthew J Kuehnert
Jul 12, 2008·Australian Veterinary Journal·C M RussellA P Begg
Feb 12, 2009·Journal of Medical Microbiology·Mamie HuiChiu-Yeung Chan
Jun 12, 2013·Diagnostic Microbiology and Infectious Disease·Kensuke ShojiIsao Miyairi
Aug 1, 2015·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·S Hernández-BouC Rodrigo Gonzalo de Liria
May 26, 2016·Enfermedades infecciosas y microbiología clínica·Manuel Monsonís CabedoAmadeu Gené Giralt
Jun 5, 2015·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Ian OngChia-Yin Chong
Oct 4, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yu-Shen ChenYao-Shen Chen
Sep 1, 2017·The Pediatric Infectious Disease Journal·Itai GrossSaar Hashavya
Nov 23, 2017·Journal of the Pediatric Infectious Diseases Society·Nathan Messbarger, Kari Neemann
Nov 23, 2017·Journal of the Pediatric Infectious Diseases Society·Sagori Mukhopadhyay, Karen M Puopolo
Oct 23, 2019·The Journal of Applied Laboratory Medicine·Tama ThéUNKNOWN with the Pediatric Emergency Medicine Collaborative Research Committee (PEM-CRC)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.